Home News Drug Research

Drug Research

FDA Raids in Florida Suggest Trump Admin. Policy Change That Benefits Big Pharma

News of the raids follows the president's nomination of a former drug company executive to serve as secretary of the Department of Health and Human Services New Delhi, December 01, 2017: The U.S. Food and Drug Administration (FDA) raided nine...

Nifty Pharma index in the red; Cipla, Lupin top drags 

New Delhi, November 27, 2017: Pharma stocks CiplaBSE -0.46 % (down 1.70 per cent), GlaxoSmithKline PharmaceuticalsBSE -0.79 % (down 0.92 per cent) and LupinBSE 0.30 % (down 0.42 per cent) were trading down in afternoon trade on Monday, dragging the...

Warning over ‘handful’ of scientists researching new antibiotics

There are now less than 500 scientists studying antimicrobial resistance (AMR) worldwide and the UK government is losing focus on the public health crisis it could cause, experts have said at the launch of a new specialist research centre. New...

Cyclopharm Ltd, Bldg 75 Business & Technology Park New Illawarra Road Lucas Heights NSW...

Name : Cyclopharm Ltd Address : Bldg 75 Business & Technology Park New Illawarra Road Lucas Heights NSW 2234 Australia PO Box 350, Menai Central NSW 2234 Australia Tel No: 61 2 9541 0411 Email : enquiries@cyclopharm.com.au...

Ranbaxy doubts staff involvement behind issues at Toansa plant

Mumbai February 10, 2013:- After the US Food and Drug Administration (USFDA) raised concerns over Ranbaxy’s largest drug ingredient plant at Toansa, many questions regarding the GMP compliance have come up. The company is making every attempt to investigate...

PLAC Test to Determine Cardiovascular Diseases

Mumbai July 10, 2014: Metropolis Healthcare Ltd, India’s leading multinational chain of diagnostic centers has become one of the few laboratories in Asia to offer PLAC Test. It is a risk stratification test which identifies the enzyme in the...

Sanofi Signs Agreement with Mannkind Corp to Develop and Market Insulin Inhaler

New Delhi, August 13, 2014 - French drugmaker Sanofi is trying to build insulin inhaler that would help diabetics from the requirement of taking insulin injections. For the same, Sanofi has signed a worldwide licensing agreement with MannKind Corp...

Aurobindo Pharma gets USFDA nod to sell antibiotic oral suspension

New Delhi, April 16, 2015 : Aurobindo PharmaBSE 4.01 % today said it has got final approval from the US Food and Drug Administration (USFDA) to make and sell its generic version of oral suspension of antibiotic Cefixime. The...

Aurobindo Pharma receives final approvals for Nafcillin Injections

Aurobindo Pharma Limited is pleased to announce that the company has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Nafcillin for Injection USP, packaged in 1g and 2g vials (ANDA 091613) and  Nafcillin for Injection USP 10g/Vial Pharmacy Bulk Package (ANDA 091614). The products are ready for launch. Nafcillin for Injection is a sterile semisynthetic  penicillin (SSP) indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. It may be used to initiate therapy in  suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results.

Plea to encourage generic drugs

KOCHI, MAY 23, 2014: The All-Kerala Chemists and Druggists Association has urged the government to encourage the marketing of life-saving medicines in generic names and not as branded ones so that patients will get them at lower prices. AN...